Malic Acid

Malic Acid

SCHEMBL21145167

CC(C)N(C(C)C)C(C)C.CC(C)N(C(C)C)C(C)C.O=C(O)CC(O)C(=O)O

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDRD2HTR1BHTR1DHTR1F

The experimentally established mechanism targets of Malic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.68
TET2 Q6N021 6/20 0.41
TET3 O43151 2/20 0.41
TET1 Q8NFU7 1/20 0.41
SLC22A6 Q4U2R8 1/20 0.40
KDM4A O75164 2/20 0.39
KDM4C Q9H3R0 2/20 0.39
KDM2A Q9Y2K7 2/20 0.39
OR51E2 Q9H255 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.35
GABRR1 P24046 2/20 0.34
LMNA P02545 1/20 0.34
GPR84 Q9NQS5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Malic Acid SCHEMBL21145168 1.00 SMN1; SMN2 (0.68) SMN1; SMN2TET2TET3TET1SLC22A6
Malic Acid SCHEMBL5874562 0.86 SMN1; SMN2 (0.68) SMN1; SMN2TET2TET3TET1SLC22A6
Malic Acid SCHEMBL28852027 0.85 SMN1; SMN2 (0.83) SMN1; SMN2TET2TET3TET1SLC22A6
Malic Acid SCHEMBL27749964 0.85 SMN1; SMN2 (0.94) SMN1; SMN2TET2TET3TET1SLC22A6
Malic Acid SCHEMBL5874761 0.83 SMN1; SMN2 (0.79) SMN1; SMN2TET2TET3TET1SLC22A6
Malic Acid SCHEMBL5874756 0.83 SMN1; SMN2 (0.79) SMN1; SMN2TET2TET3TET1SLC22A6
Malic Acid SCHEMBL29612 0.83 SMN1; SMN2 (0.79) SMN1; SMN2TET2TET3TET1SLC22A6
Malic Acid SCHEMBL9782806 0.83 SMN1; SMN2 (0.88) SMN1; SMN2TET2TET3TET1SLC22A6
Malic Acid SCHEMBL27579591 0.83 SMN1; SMN2 (0.88) SMN1; SMN2TET2TET3TET1SLC22A6
Malic Acid SCHEMBL31188091 0.83 SMN1; SMN2 (0.88) SMN1; SMN2TET2TET3TET1SLC22A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200179254-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2020-06-11 US disclosed
US-20190240129-A1 CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2019-08-08 US disclosed
EP-3518878-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION Henkel AG & Co. KGaA (DE) 2019-08-07 EP disclosed
US-20190216703-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2019-07-18 US disclosed
US-20190216714-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION HENKEL AG & CO. KGAA (DE) 2019-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190240129-A1 CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, CUTA, S100A10 SMN1; SMN2 3900/4885TET2 1413/4885TET3 894/4885
US-20190216703-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, SRRM2, IK SMN1; SMN2 4150/4885TET2 3830/4885TET3 3424/4885
US-20190216714-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, CD44, PCNA SMN1; SMN2 2681/4885TET2 562/4885TET3 438/4885
US-20200179254-A1 IMPROVED CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION KRT18, CUTA, DSG1 SMN1; SMN2 3725/4885TET2 193/4885TET3 126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.